The short answer
PI-RADS 4 means clinically significant cancer is likely, and PI-RADS v2.1 says biopsy should be considered. Pooled data put the chance at about 40%, so the next decision is how to sample, not whether to.
A score of 4 requires the lesion to be under 1.5 cm and still inside the gland; at 1.5 cm or with spread outside it, the score becomes 5.
Across 56 studies, about 40% of PI-RADS 4 lesions held clinically significant cancer on targeted biopsy.
Targeted cores alone missed some significant cancers, which is why many teams take systematic cores in the same sitting.
Choose how you want to understand this
The full explanation.
What the score commits to
PI-RADS v2.1 defines category 4 as high: clinically significant cancer is likely to be present.
The same document adds a rare piece of direct advice. Biopsy should be considered for PI-RADS 4 or 5, it says, and not for 1 or 2.
So a 4 usually moves the conversation on. The open question is no longer whether to sample the prostate, but how.
Under 1.5 cm, and still inside the gland
The line between a 4 and a 5 is mostly a tape measure.
In the outer peripheral zone, a diffusion score of 4 means a focal spot that is markedly dark on the ADC map and markedly bright on the high b-value images, measuring under 1.5 cm.
In the inner transition zone, a T2 score of 4 means a lens-shaped or poorly outlined area of moderate darkness, again under 1.5 cm.
Both definitions end the same way. At 1.5 cm or larger, or with definite spread outside the prostate, the score becomes 5.
That matters when you read your own report. A 4 has been measured, and it has been judged to be still inside the gland.
The odds behind a 4
A meta-analysis pooled 56 studies covering 16,537 men, scored with PI-RADS version 2. It reported how often a targeted biopsy of a lesion actually found clinically significant cancer:
- PI-RADS 3 — about 13%
- PI-RADS 4 — about 40%
- PI-RADS 5 — about 69%
So roughly two in five PI-RADS 4 lesions held significant cancer, and roughly three in five did not.
The same analysis found the figure moves with context. Among men who had never been biopsied it was about 42%; among men with a prior negative biopsy, about 32%.
Targeted cores, systematic cores, or both
A targeted biopsy aims at the lesion. A systematic biopsy samples the whole gland in a set pattern. They answer different questions.
The pooled analysis found targeted biopsy missed about 6% of significant cancers in PI-RADS 4 lesions. Its authors concluded that the added value of systematic sampling for finding significant cancer is fairly low, but that it still improves risk assessment and staging.
NCI's health professional summary sets out the same tension from two studies. A multicenter randomized trial of 500 men found MRI-directed biopsy more accurate than standard transrectal biopsy, with fewer biopsies overall. A single-center study of 2,103 men with MRI-visible lesions found that targeted cores alone misclassified 8.8% of the cancers defined as significant, compared with doing both.
Neither study followed men's health over time. Both measured what the pathology showed on the day.
What the biopsy adds that the scan cannot
The MRI gives a probability. It cannot give a grade.
Only tissue produces a Gleason score and a Grade Group, tells you how many cores were involved, and shows how much of each core held cancer. Those are the numbers that shape whether treatment or monitoring is offered.
That is worth saying plainly: a PI-RADS 4 is a reason to look, not a result.
Getting ready for the appointment
- Ask whether the biopsy is targeted, systematic, or both.
- Ask whether it will be done through the rectum or through the skin behind the scrotum.
- Ask who reads the images and who lines them up with the ultrasound.
- Ask when results usually come back, and who calls.
- Bring your PSA history and the MRI report itself.
Questions worth asking
- What size was the lesion, and was the gland margin clear?
- How good was the image quality?
- How many cores are planned, and from where?
- If the result is negative, do we repeat the MRI or the biopsy?
- Would a second read of the images change anything?
Related reading
For the equivocal score below this one, see What Does PI-RADS 3 Mean. For the scale itself, see What Does PI-RADS Mean. See also Biopsy and Prostate Cancer.
Sources
Words to know
Tap any term to see what it means.
Common questions
Does PI-RADS 4 mean cancer?
No. It means significant cancer is likely to be present on imaging. In a meta-analysis of 56 studies and 16,537 men, about 40% of PI-RADS 4 lesions contained clinically significant cancer on targeted biopsy.
What makes a lesion a 4 rather than a 5?
Size and containment. In PI-RADS v2.1, a 4 is under 1.5 cm and confined to the prostate. The same appearance at 1.5 cm or more, or with definite spread outside the gland, is scored 5.
Will a targeted biopsy be enough?
That is the question to ask. Pooled data found targeted biopsy missed about 6% of significant cancers in PI-RADS 4 lesions, and adding systematic cores helps with risk assessment and staging.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-21 what this meansLast updated: 2026-08-10Next planned review: 2027-07-21
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share